Showing posts with label Hydroxyapatite-coated Femoral Components Market Research Report. Show all posts
Showing posts with label Hydroxyapatite-coated Femoral Components Market Research Report. Show all posts

Thursday, July 18, 2019

To Drive Global Hydroxyapatite-coated Femoral Components Market over the Forecast Period: Ken Research

Hydroxyapatite-coated femoral components define as hard tissue implant material coated by hydroxyapatite (HA) on femur components with titanium as a base and physically or chemically. HA is a naturally mineral form of calcium apatite. The coating is plasma-sprayed which is biocompatible and has osteoconductive properties contributing to early fixation of total joint prostheses. This coating enhances endosteal bone in growth to prosthesis, consequently improving the stability of femoral stem & resulting in better clinical or radiological outcomes. HA coated femoral components are used in total hip arthroplasty (THA). They are also used in various clinical dental practices for instance the reconstruction of periodontal bone defects; filling bone defects after apicoectomy, after cystectomy, and after the loss of dental implants; and mounting the thickness of atrophic alveolar ridges. It improves implant in-growth & long-term stability with the components exhibiting preferable bone attachment on micro textured areas & little bone on the smoother areas. The coating microstructure are different between three coatings which persists to be prosthesis surface, ranging from fully crystalline coatings made with vacuum plasma spraying to less crystalline coatings pretend by air plasma spraying.

The major benefits includes the attainment of early stability, accelerated bone on growth of the surface of prosthesis are further reduced as micro-motion of the prosthesis in early post-operative period. Apart from benefits, few of the challenges impacting the market include potential for delamination and high cost of the HA coating, which results in third-body wear of polyethylene acetabular cup or subsequent osteolysis &loosening of the prosthesis.
According to study, “Global Hydroxyapatite-coated Femoral Components Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” key companies currently operating in the global hydroxyapatite-coated femoral components market areZimmer Biomet, Nano Interface Technology, Stryker, Smith & Nephew, DePuy Synthes, Exactech, MicroPort, Kycera Medical. The key vendors completely focus over the improvement in the ground breaking technologies and listening to the consumer’s preferences; which directs to the vast & continuous increase in market growth rate.
Based on type, globalhydroxyapatite-coated femoral components market is segmented into revision and primary. Based on coating technique, market is split into sputter coating, dips coating, hot pressing & hot isostatic pressing coating, pulsed laser deposition coating, thermal spraying coating, electrophoretic deposition coating and sol-gel coating. Based on end-users, market is categorized into clinic and hospitals.
The global hydroxyapatite-coated femoral components market is driven by growing demand for implants, followed by continuous research & development (R&D) activities to boost the applicability of hap in the medical industry, rising disposable income and rise in geriatric population. However, unmet performance benchmark & increasing popularity of bioresorbable composites and unfavorable healthcare reforms are expected to remain hampering factors of the market. In addition, easy availability of raw materials and growing healthcare industry are few of the areas providing the major opportunity to the market.
In 2019, value of global hydroxyapatite-coated femoral components market is reached at US $1110 million and it is predicted that it will be reached at US $1600 million, by 2024. It is estimated that the over the forecast period of market to be bright due to rapid growth in the medical tourism, followed by rapid developing infrastructure of the medical sector and increasing awareness among masses associated with the cost-effective treatments.
To know more, click on the link below:-
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249